The series of needles NovoFine combines the newer clinical findings with the state of the art for the manufacture of needles causing significantly less pain and require less pressure to give the injection.
The short 6mm needles contribute to more predictable insulin absorption significantly reducing the risk of intramuscular injection.
The needles NovoFine constructed to be used with delivery systems Novo Nordisk.
